Skip to main content
Clinical Trials/ISRCTN45257322
ISRCTN45257322
Completed
未知

Double-blind, placebo-controlled randomised trial of alpha-tocopherol and oxpentifylline in patients with radiation fibrosis

Cancer Research UK (CRUK) (UK)0 sites0 target enrollmentJuly 1, 2001

Overview

Phase
未知
Intervention
Not specified
Conditions
Breast cancer
Sponsor
Cancer Research UK (CRUK) (UK)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

  1. 2004 results in https://www.ncbi.nlm.nih.gov/pubmed/15542159 (added 25/01/2019)
Registry
who.int
Start Date
July 1, 2001
End Date
December 31, 2001
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Cancer Research UK (CRUK) (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Past history of early breast cancer (T1\-3 N0 M0\)
  • 2\. No axillary surgery or lower axillary sampling only
  • 3\. Radiotherapy to the breast/chest wall plus axilla and or stem cell factor (SCF)
  • 4\. A minimum of 5 years post\-radiotherapy
  • 5\. No evidence of cancer recurrence
  • 6\. Disabilities due to previous radiotherapy
  • 7\. Ability to attend RMT Sutton for assessments
  • 8\. Written informed consent

Exclusion Criteria

  • Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials